Requests
18
Keep in touch with meI'm using Intch to connect with new people. Use this link to open chat with me via Intch app
Work Background
AshlandSenior Director, Global Strategic Marketing & Business Development, Life Sciences
Mar. 2022 - Jun. 2024Wilmington, Delaware, United States
BGB EnterprisesStrategy Consultant
Jan. 2016 - Mar. 2022•BGB is a business management and strategy consulting firm providing services to the world’s leading agriculture, biotechnology and animal health companies. BGB has significant experience delivering expertise and consulting services including strategic decision support, merger and acquisition support, valuation of new technologies, formation of alliances, go to market strategies, and marketing research.
•Specific areas of concentration include pharmaceuticals, specialty pharmaceuticals, biologicals (vaccines), biotechnology, medical devices, genetics, technology enabled medical approaches and agriculture.
•Developed market analysis, valuation and go to market strategy plan/options for novel stem cell technology in Phase III development
•Designed go to market strategy for new to the world rDNA-based product including market evaluation and novel product delivery system. •Evaluated market opportunity and valuation for specialty pharmaceutical to induce appetite in anemic patients.
•Marketing consultation encompasses all aspects of multichannel execution across B2B and B2C strategies via traditional channels, social media, public relations, corporate communications and financial institution messaging as well as pre-clinical strategies, market preparation, launch plans, portfolio optimization, life-cycle management and pricing strategies.
SanofiExecutive Director, Head of US Marketing
Dec. 2013 - Dec. 2015Duluth, GA• Led team of 35 and grew the U.S. Pets business unit from $800M to $1B in revenue managing $150M in A&P investment; also responsible for development, implementation, and execution of tactical plans for prelaunch market shaping and strategic brand launch plans, including agency management, cross-functional alignment, and plan optimization for best ROI.
• Developed and established branding and marketing campaign that was leveraged globally; maximized market research quantitative analysis for better understanding of customer behaviors; drove commercial assessment of selected life cycle management programs.
• Led team in orchestrating the most successful product launch in animal health history (NexGard); established unprecedented clinic penetration (70%), market share gain, and speed in obtaining status as the #1 veterinary dispensed flea/tick product in the U.S.
• Drove portfolio-based strategy that rejuvenated Heartgard growth trajectory and made brand the best-selling product on the market.
• Delivered 18% growth (2015) and 13% growth (2014) in Y-O-Y revenues.
PfizerMarketing Director
Jun. 2005 - Dec. 2013•Various marketing leadership positions global and domestic across therapeutic areas.
•Led teams of 6-8 and achieved >100% of budget through eight consecutive years across various businesses including vaccines, oncology, pain management, sedation, and specialty therapeutics. •Devised and executed marketing strategy to solidify business ahead of generic competitors to osteoarthritis, drove a 24% increase in volume ahead of generic launch and prevented volume erosion to generic launches, yielding just 5% in revenue over two years. •Drove strategy for specialty therapeutic which resulted in 142% growth (from $24M to $58M) in 2014 by leveraging research that discovered pressure points with doctors and customer experience stemming from motion sickness and post-surgical nausea.
•Orchestrated new strategy for Oncology Portfolio leveraging KOL network and referral program to double revenue growth with specialty clinics. •Led turnaround efforts on the genetics business by repositioning the value proposition to focus on the value of outcomes delivered by DNA insights while providing tools for them to quantify their investment; reversed revenue slide and grew business by 85%.
•Evaluated food safety M&A opportunities which led to company acquisition, licensure of two new products, and establishment of new business vertical; expansion spurred tens of millions of dollars in revenue growth.
• business transitioned to Zoetis via IPO February 1, 2013.
RSC, The Quality Management CompanyVice President, North America
Jun. 1995 - Jun. 2005• Led team of 15 responsible for direct-to-consumer (DTC) advertising evaluations for CPG and pharmaceutical organizations, driving double-digit growth for seven consecutive years while increasing market share performance for more than 80% of clients.
• Developed DTC evaluation for pharmaceutical advertising, building a new vertical for the company; new growth generated more than 25% of total company revenues.
Intch is a Professional Networking App for the Future of WorkSee more people like Brandt on Intch
300k+ people
130+ countries
AI matching
Get Intch if you'd like to
702932 people
24
Partnership Marketing @ DonorsChoose
19
Marketing Creative Director
19
Founder @ Beagle
96325 people
18
Owner @ Douglas Fisher Creative
15
Chief Digital Officer @ Gray Dot Co
15
Chief Marketing Officer @ Kahana